Access cutting-edge coronary artery disease treatment through this clinical trial at a research site in Springfield. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Springfield location
Preparing your pre-screening questions…
Access coronary artery disease specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related coronary artery disease treatment provided free
Check if you qualify for this coronary artery disease clinical trial in Springfield, MA
No-Cost Study Care
Local to Springfield
Convenient for MA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The primary hypothesis of ROMA is that in patients undergoing primary isolated non-emergent coronary artery bypass surgery (CABG), the use of two or more arterial grafts compared to a single arterial graft is associated with a reduction in the composite outcome of death from any cause, any stroke, post discharge myocardial infarction and/or repeat revascularization. The secondary hypothesis is that in patients undergoing primary isolated non-emergent CABG, the use of two or more arterial grafts compared to a single arterial graft is associated with improved survival. Prospective event-driven unblinded randomized multicenter trial of at least 4,300 subjects enrolled in at least 25 international centers. Patients will be randomized to a single arterial graft (SAG) or multiple arterial grafts (MAG). Patients will be randomized in a 1:1 fashion between the two groups. Permuted block randomization with random blocks stratified by the center and the type of second arterial graft will be used to provide treatment distribution in equal proportion.
Sponsor: Weill Medical College of Cornell University
Yes, this clinical trial (NCT03217006) has an active research site in Springfield, MA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for coronary artery disease treatment options in Springfield, MA, this clinical trial (NCT03217006) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Springfield research site is actively enrolling participants for this clinical trial. You'll receive care from experienced coronary artery disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all coronary artery disease clinical trials near you to find additional studies recruiting in your area.
See all heart disease clinical trials recruiting in Springfield — not just this study.
Browse Heart Disease Trials in Springfield →